ArticleJournal of diabetes investigation2016

CYP2C93 variant is associated with antidiabetes efficacy of gliclazide in Chinese type 2 diabetes patients.

Wotan Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.